Patents by Inventor Mohamed El Yazidi

Mohamed El Yazidi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treatment of esophageal cancer
    Publication number: 20090232907
    Abstract: Novel ureyl-substituted naphthalimide derivatives, pharmaceutically acceptable salts thereof and solvates thereof, are useful for making pharmaceutical compositions for the treatment of cell proliferative diseases such as cancer. The invention also provides methods of treating specific types of cancer such as prostate, esophageal, glioblastoma, gliosarcoma, NSCLC, head and neck, and breast with the compounds described herein alone and in combination with antineoplastic agents.
    Type: Application
    Filed: November 17, 2008
    Publication date: September 17, 2009
    Applicant: Unibioscreen S.A.
    Inventors: Eric Van Quaquebeke, Gentiane Simon, Mohamed El Yazidi, Jerome Tuti, Laurent Van Den Hove, Francis Darro, Robert Kiss
  • Compositions and methods for treatment of prostate and breast cancer
    Publication number: 20090221628
    Abstract: Novel ureyl-substituted naphthalimide derivatives, pharmaceutically acceptable salts thereof and solvates thereof, are useful for making pharmaceutical compositions for the treatment of cell proliferative diseases such as cancer. The invention also provides methods of treating specific types of cancer such as prostate, esophageal, glioblastoma, gliosarcoma, NSCLC, head and neck, and breast with the compounds described herein alone and in combination with antineoplastic agents.
    Type: Application
    Filed: November 17, 2008
    Publication date: September 3, 2009
    Applicant: Unibioscreen S.A.
    Inventors: Eric Van Quaquebeke, Gentiane Simon, Mohamed El Yazidi, Jerome Tuti, Laurent Van Den Hove, Francis Darro, Robert Kiss
  • Compositions and methods for treatment of glioblastoma, gliosarcoma, NSCLC, and head and neck cancer
    Publication number: 20090186915
    Abstract: Novel ureyl-substituted naphthalimide derivatives, pharmaceutically acceptable salts thereof and solvates thereof, are useful for making pharmaceutical compositions for the treatment of cell proliferative diseases such as cancer. The invention also provides methods of treating specific types of cancer such as prostate, esophageal, glioblastoma, gliosarcoma, NSCLC, head and neck, and breast with the compounds described herein alone and in combination with antineoplastic agents.
    Type: Application
    Filed: November 17, 2008
    Publication date: July 23, 2009
    Applicant: Unibioscreen S. A.
    Inventors: Eric Van Quaquebeke, Gentiane Simon, Mohamed El Yazidi, Jerome Tuti, Laurent Van Den Hove, Francis Darro, Robert Kiss
  • 5-Urea Substituted Naphthalimide Derivatives, Methods of Production and Pharmaceutical Compositions for Treating Cancer
    Publication number: 20090118321
    Abstract: Novel ureyl-substituted naphthalimide derivatives, pharmaceutically acceptable salts thereof and solvates thereof, are useful for making pharmaceutical compositions for the treatment of cell proliferative diseases such as cancer. The invention also provides methods for making such derivatives through hydrolysis of known compounds.
    Type: Application
    Filed: May 7, 2007
    Publication date: May 7, 2009
    Applicant: Unibioscreen S.A.
    Inventors: Eric Van Quaquebeke, Gentiane Simon, Mohamed El Yazidi, Jerome Tuti, Laurent Van den Hove, Francis Darro, Robert Kiss
  • Extract with anti-tumor and anti-poisonous activity
    Publication number: 20060057237
    Abstract: Extracts of the plant Calotropis procera, having a pharmacological activity, in particular an anti-poisonous activity, and active compounds isolated thereof are described. Furthermore, methods for the extraction of the extracts are disclosed. Also, a pharmaceutical composition or product for the treatment of cancer which includes an effective amount of the described extracts or an active compound thereof, a therapeutic compound and optionally a pharmaceutical acceptable carrier are described.
    Type: Application
    Filed: October 9, 2003
    Publication date: March 16, 2006
    Inventors: Francis Darro, Jean-Claude Braekman, Pierre Guissou, Odile Nacoulma, Mohamed El Yazidi, Janique Dewelle, Rob Van Ginkel, Marc Van Damme, Robert Kiss